CSRxP Commends Administration for Commitment to DTC Advertising Rule
Aug 21, 2019
Applauds HHS For Appealing Ruling Against List Price Transparency Measure… Read More
© 2024 CSRXP- All Rights Reserved
Updates
Second Opinion: GAO Undermines Common Refrain in Big Pharma’s Blame Game
Aug 16, 2019
Analysis Finds PBMs Pass On Over 99 Percent of Rebates, Used to Keep Premiums… Read More
Q2 Earnings: Big Pharma Keeps Living the Good Life While Evading Accountability
Jul 31, 2019
Q2 Earnings: Big Pharma Keeps Living the Good Life While Evading… Read More
Big Pharma Earnings Watch: Amgen, Eli Lilly, Merck and Pfizer
Jul 31, 2019
Four More Rx Giants Complete the Sweep, Beat Q2 Earnings Forecasts After… Read More
Big Pharma Earnings Watch: AbbVie and Sanofi
Jul 30, 2019
Brand Name Drug Makers Continue to Surpass Q2 Forecasts After Hiking Prices… Read More
Big Pharma Earnings Watch: Bristol-Myers Squibb, AstraZeneca, Roche
Jul 29, 2019
Three More Drug Makers Top Earnings Expectations in Q2 Today three more… Read More
CSRxP: Senate Finance Takes Positive Steps to Hold Big Pharma Accountable, Lower Drug Prices
Jul 25, 2019
Commends Bipartisan Collaboration on Several Market-Based Solutions… Read More
Big Pharma Earnings Watch: GlaxoSmithKline
Jul 24, 2019
Big Pharma Giants Now Three for Three Besting Forecasts After Hiking Prices… Read More
CSRxP Applauds Grassley, Wyden for Moving Ahead on Drug Pricing Package
Jul 23, 2019
Looks Forward to Working With Senate Finance Members to Hold Big Pharma… Read More
Big Pharma Earnings Watch: Novartis
Jul 18, 2019
Drug Makers’ Shares Hit ‘All-Time High’ Off Of Price-Gouging American… Read More
Big Pharma Earnings Watch: Johnson & Johnson
Jul 17, 2019
Drug Maker Bests Q2 Forecasts After Hiking Prices on Dozens of Drugs in 2019… Read More
CSRxP Encourages House E&C Lawmakers to Advance FAIR Drug Pricing Act
Jul 16, 2019
Greater List Price Transparency Will Help Hold Big Pharma Accountable… Read More